Jonathan R Lindner Selected Research

APOBEC-1 Deaminase

1/2021	Echocardiographic Molecular Imaging of the Effect of Anticytokine Therapy for Atherosclerosis.
11/2018	Assessment of Novel Antioxidant Therapy in Atherosclerosis by Contrast Ultrasound Molecular Imaging.
7/2015	Molecular Imaging of Platelet-Endothelial Interactions and Endothelial von Willebrand Factor in Early and Mid-Stage Atherosclerosis.
1/2010	Molecular imaging of the initial inflammatory response in atherosclerosis: implications for early detection of disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jonathan R Lindner Research Topics

Disease

19	Ischemia 01/2022 - 06/2005
16	Atherosclerosis 06/2022 - 07/2007
12	Inflammation (Inflammations) 01/2019 - 04/2002
9	Neoplasms (Cancer) 01/2021 - 07/2003
9	Infarction (Infarctions) 11/2018 - 04/2002
5	Myocardial Infarction 01/2021 - 11/2005
4	Hypersensitivity (Allergy) 01/2022 - 01/2021
4	Myocardial Ischemia (Ischemic Heart Diseases) 11/2021 - 10/2012
4	Pathologic Constriction (Stenosis) 09/2021 - 02/2002
4	Hyperinsulinism (Hyperinsulinemia) 01/2016 - 03/2002
3	Peripheral Arterial Disease 01/2020 - 03/2017
3	Thrombosis (Thrombus) 01/2019 - 07/2009
3	Insulin Resistance 01/2019 - 04/2015
3	Hemorrhage 03/2016 - 12/2012
3	Obesity 01/2016 - 05/2006
3	Ventricular Remodeling 02/2014 - 07/2002
2	Infections 01/2022 - 07/2002
2	Chest Pain (Chest Pains) 09/2021 - 01/2007
2	Pain (Aches) 01/2019 - 12/2013
2	Hyperemia 05/2017 - 02/2002
2	Rupture 07/2015 - 12/2012
2	Diabetes Mellitus 04/2015 - 11/2011
2	Cardiomyopathies (Cardiomyopathy) 02/2014 - 11/2005
2	Acute Coronary Syndrome 08/2013 - 04/2002
2	Reperfusion Injury 10/2012 - 01/2010
1	Abscess 01/2022
1	ST Elevation Myocardial Infarction 11/2021
1	Unstable Angina 11/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Zika Virus Infection 01/2020
1	Vascular Diseases (Vascular Disease) 01/2020
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020
1	Leukemia 01/2020
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2019
1	Thrombotic Microangiopathies 01/2019
1	Hypercholesterolemia 01/2019
1	Atherosclerotic Plaque (Atheroma) 01/2018
1	Sickle Cell Anemia (Hemoglobin S Disease) 03/2017

Drug/Important Bio-Agent (IBA)

9	Contrast MediaIBA 08/2021 - 01/2006
6	Insulin (Novolin)FDA Link 01/2021 - 05/2006
6	P-SelectinIBA 01/2016 - 08/2007
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2022 - 08/2007
5	LDL Receptors (LDL Receptor)IBA 01/2021 - 01/2010
4	APOBEC-1 DeaminaseIBA 01/2021 - 01/2010
4	von Willebrand FactorIBA 10/2020 - 01/2015
4	Glycoproteins (Glycoprotein)IBA 11/2018 - 06/2005
4	LigandsIBA 01/2018 - 09/2007
4	Vasodilator Agents (Vasodilators)IBA 08/2017 - 11/2011
4	SelectinsIBA 01/2016 - 11/2011
4	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 03/2002
3	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 06/2022 - 07/2007
3	PhosphatidylserinesIBA 11/2021 - 04/2002
3	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 08/2021 - 01/2021
3	LipidsIBA 01/2021 - 04/2002
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2019
3	Adenosine (Adenocard)FDA LinkGeneric 01/2019 - 03/2005
3	Peptides (Polypeptides)IBA 01/2018 - 01/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2012 - 07/2002
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2007 - 06/2005
2	Tyrosine (L-Tyrosine)FDA Link 01/2022 - 01/2021
2	regadenoson FDA Link 09/2021 - 01/2019
2	AntioxidantsIBA 11/2018 - 01/2013
2	IntegrinsIBA 01/2017 - 06/2005
2	Platelet Membrane GlycoproteinsIBA 01/2017 - 06/2005
2	DNA (Deoxyribonucleic Acid)IBA 05/2011 - 08/2007
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 11/2007 - 09/2007
2	Peroxidase (Myeloperoxidase)IBA 07/2002 - 04/2002
1	ibrutinibIBA 06/2022
1	COVID-19 VaccinesIBA 01/2022
1	TroponinIBA 11/2021
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2021
1	contrast agent BR1IBA 01/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	ponatinibIBA 01/2019
1	LDL CholesterolIBA 01/2019
1	Lipoproteins (Lipoprotein)IBA 01/2019
1	Molecular Probes (Molecular Probe)IBA 01/2019
1	Metalloproteases (Metalloproteinases)IBA 11/2018
1	Peptide Hydrolases (Proteases)FDA Link 11/2018
1	DisintegrinsIBA 11/2018
1	ThrombospondinsIBA 11/2018
1	FS 069 (Optison)FDA Link 05/2017
1	3-nitrotyrosineIBA 03/2016
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 03/2016

Therapy/Procedure

22	Microbubbles 11/2021 - 04/2002
16	Therapeutics 01/2021 - 07/2002
6	Ligation 11/2018 - 06/2005
2	Percutaneous Coronary Intervention 11/2021 - 04/2006
2	Catheters 01/2021 - 07/2014
2	Injections 07/2002 - 02/2002
1	Heart-Assist Devices 01/2022
1	Defibrillators (Defibrillator) 01/2022
1	Catheter Ablation 01/2021
1	Blood Component Removal (Apheresis) 01/2019
1	Carotid Endarterectomy 01/2018
1	Ultrasonic Therapy 03/2017
1	Intravenous Injections 03/2017